Skip to content
Screener

BioMarin Pharmaceuticals BMRN Raw materials

Raw materials at other companies

Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$15K-28.6%
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
$374K+320%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$27.85M—
Denali Therapeutics Inc. logo
Denali Therapeutics Inc.DNLI
$0—
Krystal Biotech, Inc. logo
Krystal Biotech, Inc.KRYS
$15.17M+0.2%

Other financials

Income statement

See full
Revenue$989.7M+19.9%
Gross profit$786.9M+16.5%
Operating income$110.9M-59.9%
Net income$44.8M-81.4%
EPS (diluted)$0.23-81.3%

Balance sheet

See full
Cash & equivalents$874.0M-28.0%
Total debt$4.2B+598%
Total equity$6.3B+4.9%
Total assets$11.7B+57.2%

Cash flow

See full
Operating cash flow$168.1M-9.3%
CapEx$28.8M+68.5%
Free cash flow$139.3M-17.2%

Valuation

See full
Market cap$12.35B+12.2%
Enterprise value$15.66B+50.7%
P/E34.3×-37.0×
P/S3.6×0.0×

Profitability

See full
Gross margin76.1%-3.4pp
Operating margin19.9%+7.2pp
Net margin16.8%+5.1pp
FCF margin21.7%-1.0pp

Returns & leverage

See full
Return on equity9.1%+2.8pp
Debt / equity0.7×+0.6×
Current ratio2.4×-3.2×

Where this comes from

Reported directly by BioMarin Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:InventoryRawMaterialsNetOfReserves.

The source filing: BioMarin Pharmaceuticals’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:14 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001048477-26-000016
Line itemJune 30,2026December 31,2025
Raw materials$259,353$106,510
Work-in-process1,240,090801,061
Finished goods283,081391,312
Total inventory$1,782,524$1,298,883

Item 1. Financial Statements

FAQ

What is BioMarin Pharmaceuticals's raw materials?
BioMarin Pharmaceuticals (BMRN) reported raw materials of $259.35M in Q2 2026.
How has BioMarin Pharmaceuticals's raw materials changed year-over-year?
BioMarin Pharmaceuticals's raw materials increased by 116.6% year-over-year, from $119.75M to $259.35M.
What is the long-term trend for BioMarin Pharmaceuticals's raw materials?
Over 5 years (2020 to 2025), BioMarin Pharmaceuticals's raw materials has grown at a 6.8% compound annual growth rate (CAGR), from $76.67M to $106.51M.
What does raw materials mean?
Unprocessed materials and components purchased for use in manufacturing, valued at cost.

Ask your AI about BioMarin Pharmaceuticals's raw materials.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude